DEF: Goal Acquisitions Seeks Extension Amid Financial Woes

Goal Acquisitions Corp. seeks stockholder approval to extend its business combination deadline to July 31, 2027, while grappling with delinquent SEC filings and low trust account funds.

Summary

• Goal Acquisitions Corp. (the Company) is seeking stockholder approval for two proposals: to amend its certificate of incorporation to extend the deadline for completing an initial business combination to July 31, 2027 (the Charter Amendment Proposal), and to amend the Investment Management Trust Agreement to align the Trust Account liquidation date with this new deadline (the Trust Amendment Proposal).
• The current deadline for completing a business combination is February 8, 2026, which has been extended multiple times since the IPO in February 2021.
• Public stockholders have the right to redeem their shares for cash in connection with the approval of the Charter Amendment Proposal, regardless of how they vote.
• The estimated per-share redemption value is approximately $11.43, which is $0.43 higher than the common stock's closing price of $11.00 on the Record Date (January 23, 2026).
• If the proposals are not approved, the company expects to cease operations, redeem public shares, and liquidate, rendering warrants worthless.
• The Sponsor, directors, and executive officers, who beneficially own approximately 97% (7,136,250 shares) of the outstanding common stock, are expected to vote in favor of both proposals, ensuring their approval.
• The company has failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and all Quarterly Reports on Form 10-Q during 2025, citing a lack of funding.
• The remaining funds in the Trust Account are approximately $777,099.65 as of the Record Date, a significant reduction from the initial IPO gross proceeds of $258,750,000.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative development, reflecting severe operational and financial distress, regulatory non-compliance, and a significantly diminished ability to achieve its core objective. The repeated extensions and lack of funding for basic reporting are major red flags.

Positives

• The extension provides the company with additional time, until July 31, 2027, to identify and complete an initial business combination, preventing immediate liquidation.
• Public stockholders electing to redeem their shares would receive approximately $11.43 per share, which is $0.43 more than the market closing price of $11.00 on the Record Date.
• The Board of Directors unanimously recommends voting FOR the proposals, believing they are in the best interests of the company and its stockholders.

Negatives

• This is another extension, indicating persistent difficulty in finding and closing a business combination, raising concerns about the company's long-term viability.
• The company has failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and all Quarterly Reports on Form 10-Q during 2025, citing a lack of funding.
• The company does not anticipate filing any periodic reports in 2026 until all delinquent 2025 reports are filed, which will delay any potential business combination.
• The Trust Account balance has significantly diminished to approximately $777,099.65 as of the Record Date, from initial IPO proceeds of $258,750,000, reflecting substantial prior redemptions and limited remaining capital.
• If the extension is not approved, the company will liquidate, and warrants will expire worthless.
• The company may need to obtain additional funds to complete an initial business combination, with no assurance of availability on acceptable terms or at all.
• The common stock is eligible for quotation on the OTC Expert Market, which may negatively impact liquidity and attractiveness to potential business combination targets.
• A 1% U.S. federal excise tax on redemptions may decrease the cash available for a business combination.
• If the extension is implemented and redemptions occur, the percentage of shares held by the Sponsor and affiliates will increase.

Risks

• There is no assurance that the extension will enable the company to complete an initial business combination by July 31, 2027.
• Redemptions by public stockholders could leave the company with insufficient cash to consummate a business combination on commercially acceptable terms, or at all.
• The price of the company's shares may be volatile, and there is no assurance that stockholders will be able to dispose of shares at favorable prices or at all.
• The company risks being deemed an investment company under the Investment Company Act of 1940, which would severely restrict its activities and potentially lead to liquidation.
• Changes to laws or regulations, or their interpretation (e.g., the 2024 SPAC Rules), may adversely affect the company's business, including its ability to negotiate and complete an initial business combination.
• Certain acquisitions or business combinations may be subject to review or approval by regulatory authorities (e.g., CFIUS), which could delay or prevent a transaction.
• The Sponsor and the company's directors and officers have interests in the proposals that may conflict with those of other stockholders, as their founder shares and warrants would become worthless upon liquidation.
• A 1% U.S. federal excise tax may be imposed on redemptions, potentially decreasing the value of securities and funds available for a business combination or distribution.
• The common stock's eligibility for quotation on the OTC Expert Market may have an unfavorable impact on its stock price and liquidity, and make the company less attractive to business combination targets.
• The company has failed to timely file its Annual Reports on Form 10-K for the fiscal year ended December 31, 2024, and Quarterly Reports on Form 10-Q during 2025 due to a lack of funding.
• Failure to timely file required reports may adversely impact the company's ability to complete a business combination and could result in SEC enforcement actions or stockholder lawsuits.
• The company believes it will not be able to complete an initial business combination until all delinquent reports are filed, increasing the risk of liquidation.

Future Outlook

The company intends to continue seeking an initial business combination until July 31, 2027, if the extension proposals are approved. It anticipates needing additional funds to complete a business combination and to address its delinquent SEC filings. The company does not expect to file any 2026 periodic reports until all delinquent 2025 reports are filed, believing a business combination cannot be completed until reporting obligations are met. Further extensions may be sought in the future.

Management Comments

• The Board believes that the Charter Amendment Proposal and the Trust Amendment Proposal are fair to and in the best interests of the company and its stockholders.
• The Board believes that the Extension is essential to fulfill the investment purpose that stockholders entrusted to us at the time of our IPO.
• The Board believes that the proposed extension period is sufficient to complete the necessary activities to secure and finalize a business combination that meets our strategic and financial criteria.
• The Board of Directors expresses no opinion as to whether you should redeem your public shares.

Industry Context

StockSavvy.ai notes that Goal Acquisitions Corp.'s situation reflects broader challenges within the SPAC market, characterized by increased regulatory scrutiny, higher redemption rates, and difficulty in identifying and consummating suitable business combinations. The significant reduction in the Trust Account balance and the company's non-compliance with SEC reporting requirements due to funding issues are severe deviations from industry best practices and highlight the heightened risks associated with SPACs that fail to execute their initial mandate within the original timeframe.

Comparison to Industry Standards

• The company's need for another extension, following multiple prior extensions, is indicative of a prolonged struggle to identify a viable business combination, a common challenge for many SPACs in the current market environment.
• The estimated per-share redemption value of $11.43, which is higher than the market price of $11.00, suggests that public stockholders are being offered a premium to exit, a mechanism often employed by SPACs to manage redemptions and retain a sufficient cash runway.
• The failure to file Annual Reports on Form 10-K for FY2024 and Quarterly Reports on Form 10-Q during 2025 due to a lack of funding is a critical non-compliance issue, significantly below the reporting standards expected of publicly traded companies and a stark contrast to well-managed SPACs that maintain timely financial disclosures.
• The drastically reduced Trust Account balance of approximately $777,099.65, compared to the initial IPO proceeds of $258,750,000, demonstrates a high level of prior redemptions, a trend observed across the SPAC industry where investor confidence wanes as deadlines approach without a definitive deal.

Corporate Governance

Legal Proceedings

• Failure to timely file periodic reports with the SEC could subject the company to enforcement action by the SEC and stockholder lawsuits.
• Potential revocation or suspension of the registration of securities under the Exchange Act and/or regulatory sanctions from the SEC.

Related Party Transactions

• The Sponsor and directors/officers have interests that may conflict with other stockholders, as their 6,468,750 founder shares (acquired for approximately $25,000) and 667,500 private shares/warrants (acquired for $6,675,000) will be worthless if the proposals are not approved and the company liquidates.
• Officers, directors, and their affiliates have advanced certain funds to the company, which will not be repaid if the proposals are not approved and a business combination is not consummated.
• Officers, directors, and their affiliates are entitled to reimbursement of out-of-pocket expenses, which will not be repaid if the company liquidates without sufficient funds outside the Trust Account.
• Potential loans from the Sponsor are anticipated to fund the completion of delinquent reports.

Stakeholder Impact

• Shareholders (Public): Face a decision to redeem shares at a premium or hold for a potential business combination. Risk of illiquidity if selling in the open market. If the extension fails, they receive their pro rata share from the Trust Account.
• Shareholders (Sponsor/Insiders): Face complete loss of investment in founder shares and private warrants if the extension is not approved and the company liquidates. Their percentage ownership will increase if public stockholders redeem shares.
• Warrant Holders: Warrants will expire worthless if the company liquidates. If the extension is approved, warrants remain outstanding.
• Creditors: The company has obligations under Delaware law to provide for claims of creditors in the event of liquidation.
• Potential Business Combination Targets: The company's delinquent SEC filings and low Trust Account balance make it a less attractive target, potentially limiting options.

Next Steps

• Hold a Special Meeting of Stockholders on February 6, 2026, to vote on the Charter Amendment Proposal and the Trust Amendment Proposal.
• If proposals are approved, the company will continue efforts to consummate an initial business combination until July 31, 2027.
• If proposals are not approved, the company expects to cease operations, redeem public shares, and liquidate.
• Complete the preparation and filing of delinquent Annual Reports on Form 10-K for FY2024 and Quarterly Reports on Form 10-Q for 2025.
• Obtain additional funding to address delinquent reports and facilitate a business combination.
• If a business combination is identified, seek stockholder approval for the proposed transaction and related matters.

Key Dates

Recommendation

The company's persistent inability to complete a business combination, coupled with severe regulatory non-compliance (delinquent SEC filings due to lack of funding) and a drastically depleted Trust Account, signals significant operational and financial distress. While an extension offers a slim chance of survival, the fundamental issues and high risk of eventual liquidation make the stock a strong sell, as the downside potential far outweighs any speculative upside.

Keywords

SPAC, Extension, Business Combination, Proxy Statement, Redemption, Liquidation, SEC Filings, Corporate Governance, Trust Account, Goal Acquisitions Corp.